IP Library › Granted Patent US 12,239,788
Granted Patent B2
US 12,239,788 · App. 17/444,168 · Granted Mar 4, 2025

Patient interface

Inventors: Michael Paul Ronayne (Auckland, NZ); Riki Zane Shearer (Auckland, NZ); Daniel Charles Wilson (Auckland, NZ); Robert Andrew David Milne (Auckland, NZ); Caroline Geraldine Hopkins (Auckland, NZ); Craig Karl White (Auckland, NZ); Puqing Zhang (Auckland, NZ)
Assignee: Fisher & Paykel Healthcare Limited
A61M16/0666A61M16/06A61M16/0605A61M16/0672A61M16/0825A61M16/0683A61M16/0688A61M2205/0216
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,239,788
App. No.
17/444,168
Granted
Mar 4, 2025
Kind
B2
Abstract

A patient interface, such as a nasal cannula, including a body to be positioned upon a user (preferably such as a user's face), the body including at least one (and preferably a pair of) nasal prong(s), the or each nasal prong including a lumen capable of being fluidly connected thereto for fluid communication with a supply of breathable gas, the or each nasal prong to be in a configuration either inserted into, or to direct a flow of gas toward, a nare or the nares of the user's nose, wherein the body includes at least one element responsive to force(s) or movement(s), or both, experienced by at least a first region of the patient interface.

Claims (42)

1. A patient interface configured to be secured to a patient's face, comprising:

an elongate body comprising a first end and a second end that is opposite of the first end;

a pair of nasal prongs positioned on the elongate body, wherein each nasal prong of the pair of nasal prongs comprise a lumen configured to be fluidly connected with a supply of breathable gas, the pair of nasal prongs comprising a first nasal prong and a second nasal prong;

a pair of elastic hinging regions incorporated as part of the elongate body;

wherein in a relaxed state, the pair of elastic hinging regions form a first crest and a second crest when viewed from a top of a patient's head when the patient interface is in use,

wherein the first crest and second crest bend in a predefined direction with a preferential geometry relative to the rest of the patient interface when responding to force(s) applied to the patient inteface by facial movements;

wherein the elongate body comprises a single trough between the first crest and the second crest of the pair of elastic hinging regions when viewed from the top of the patient's head when the patient interface is in use, and wherein at least one elastic hinging region of the pair of elastic hinging regions is configured to deform in a predetermined direction when a force is applied to the elongate body to stabilize the pair of nasal prongs in the patient's nares and aid in securement of the patient interface to the patient's face;

wherein the pair of nasal prongs are located between the first crest and the second crest of the pair of elastic hinging regions, the first crest comprising only one bend between the first end and the first nasal prong, and the second crest comprising only one bend between the second end and the second nasal prong; and

wherein the first crest and the second crest are configured to be positioned a distance from the patient's face.

2. The patient interface of claim 1 , wherein the force is applied to a first region of the elongate body, and wherein the pair of elastic hinging regions are configured to reduce or prevent a transfer of the force applied to the first region of the elongate body from transferring to a second region of the patient interface.

3. The patient interface of claim 1 , wherein the force is applied to a first region of the elongate body, and wherein the pair of elastic hinging regions are configured to localise force experienced by the elongate body or reduce a transfer of the force from the first region of the elongate body to a second region of the patient interface.

4. The patient interface of claim 1 , wherein the pair of elastic hinging regions are configured to maintain a direction of gas into the patient's nares or maintain the pair of nasal prongs within or adjacent to the patient's nares.

5. The patient interface of claim 1 , wherein the force applied to the elongate body is a force between the pair of nasal prongs and the elongate body.

6. The patient interface of claim 1 , wherein the pair of elastic hinging regions deform by compression, tension, torsion, bending or flexing.

7. The patient interface of claim 1 , wherein the pair of elastic hinging regions deform by changing shape, or position, or configuration.

8. The patient interface of claim 1 , wherein the pair of elastic hinging regions comprise a pivoting region or articulating region.

9. The patient interface of claim 1 , wherein the pair of elastic hinging regions is deformable about at least one axis or plane.

10. The patient interface of claim 1 , further comprising one or more additional elastic hinging regions located outside of the pair of nasal prongs.

11. The patient interface of claim 1 , wherein the pair of elastic hinging regions are connected to provide for a combined response to the force.

12. The patient interface of claim 11 , wherein the pair of elastic hinging regions responds to the force differently while providing for the combined response.

13. The patient interface of claim 1 , wherein the pair of elastic hinging regions deform to facilitate a predetermined bend, flexure, twist, torsion, pivot, stretch, or compression of a material or a component of the elongate body.

14. The patient interface of claim 1 , wherein the patient interface is conformable to facial geometry such that the pair of elastic hinging regions responds to the force to maintain the patient interface in a therapy delivery configuration.

15. The patient interface of claim 1 , further comprising one or more facial pads configured to rest on the patient's face.

16. The patient interface of claim 1 , wherein the pair of elastic hinging regions are configured to bend outward away from the patient's face or downward from the patient's nose.

17. The patient interface of claim 1 , wherein the pair of elastic hinging regions comprise a variable cross-sectional area, a variable thickness, or two or more materials wherein each of the two or more materials comprise a different flexibility than each other.

18. The patient interface of claim 1 , wherein the pair of elastic hinging regions is configured to be pre-stressed before use.

19. A patient interface configured to be secured to a patient's face, comprising;

an elongate body comprising a first end and a second end that is opposite of the first end;

a pair of nasal prongs positioned on the elongate body, wherein each nasal prong of the pair of nasal prongs comprise a lumen configured to be fluidly connected with a supply of breathable gas, the pair of nasal prongs comprising a first nasal prong and a second nasal prong;

a pair of elastic hinging regions incorporated as part of the elongate body;

wherein in a relaxed state, the pair of elastic hinging regions form a first crest and a second crest, the first crest comprising only one bend between the first end and the first nasal prong and the second crest comprising only one bend between the second end and the second nasal prong;

wherein the first crest and second crest bend in a predefined direction with a preferential geometry relative to the rest of the patient interface when responding to force(s) applied to the patient inteface by facial movements;

wherein the elongate body comprises a trough between the pair of elastic hinging regions, and wherein at least one elastic hinging region of the pair of elastic hinging regions is configured to deform when a force is applied to the elongate body to stabilize the pair of nasal prongs in the patient's nares and aid in securement of the patient interface to a patient's face;

wherein the pair of elastic hinging regions are located adjacent to and outside of the pair of nasal prongs and the pair of nasal prongs are located within the trough of the elongate body;

wherein the first crest comprises a first concave surface configured to be positioned adjacent to the patient's face and a second convex surface configured to be positioned away from the patient's face; and

wherein the second crest comprises a first concave surface configured to be positioned adjacent to the patient's face and a second convex surface configured to be positioned away from the patient's face.

20. A patient interface configured to be secured to a patient's face, comprising:

an elongate body comprising:

a first crest positioned between a first nasal prong and a first end of the elongate body, wherein in a relaxed state, the first crest comprises a first concave surface configured to be positioned adjacent to the patient's face and a second convex surface configured to be positioned away from the patient's face, and wherein the first crest bends in a predefined direction with a preferential geometry relative to the rest of the patient interface when responding to force(s) applied to the patient inteface by facial movements;

a second crest positioned between a second nasal prong and a second end of the elongate body, wherein in the relaxed state, the second crest comprises a first concave surface configured to be positioned adjacent to the patient's face and a second convex surface configured to be positioned away from the patient's face, and wherein the second crest bends in a predefined direction with a preferential geometry relative to the rest of the patient interface when responding to force(s) applied to the patient inteface by facial movements; and

a trough positioned between the first crest and the second crest; and

a pair of nasal prongs comprising the first nasal prong and the second nasal prong, wherein the pair of nasal prongs are positioned within the trough.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2025
From: RONAYNE, MICHAEL PAUL; SHEARER, RIKI ZANE; WILSON, DANIEL CHARLES; MILNE, ROBERT ANDREW DAVID; HOPKINS, CAROLINE GERALDINE; WHITE, CRAIG KARL; ZHANG, PUQING
To: FISHER & PAYKEL HEALTHCARE LIMITED
Reel/Frame 069862/0679 →
Continuity (4)
Continuation 15028924
Provisional Application 61919579 · Dec 20, 2013
Provisional Application 61891697 · Oct 16, 2013
Related Publication 20210379313A1 · Dec 9, 2021
References Cited (101)
US 2693800A · Caldwell · 1954 [cited by examiner]
US 3513844A · Smith · 1970 [cited by examiner]
US 3726275A · Jackson · 1973 [cited by examiner]
US 3754552A · King · 1973 [cited by applicant]
US 4106505A · Salter · 1978 [cited by examiner]
US 4278082A · Blackmer · 1981 [cited by examiner]
US 4742824A · Payton · 1988 [cited by examiner]
US 4753233A · Grimes · 1988 [cited by examiner]
US 5269296A · Landis · 1993 [cited by examiner]
US 5271391A · Graves · 1993 [cited by examiner]
US 5687715A · Landis · 1997 [cited by examiner]
US 6298850B1 · Argraves · 2001 [cited by examiner]
US 7406966B2 · Wondka · 2008 [cited by applicant]
US 7614401B2 · Thompson · 2009 [cited by examiner]
US 8025058B2 · Chandran et al. · 2011 [cited by applicant]
US 8136527B2 · Wondka · 2012 [cited by examiner]
US 11058841B2 · Johnson et al. · 2021 [cited by applicant]
US 11110242B2 · Ronayne · 2021 [cited by examiner]
US 20010029954A1 · Palmer · 2001 [cited by applicant]
US 20020046755A1 · De Voss · 2002 [cited by applicant]
US 20030079749A1 · Strickland et al. · 2003 [cited by applicant]
US 20030116163A1 · Wood · 2003 [cited by examiner]
US 20030126724A1 · Kono et al. · 2003 [cited by applicant]
US 20030135192A1 · Guralski et al. · 2003 [cited by applicant]
US 20040226566A1 · Gunaratnam et al. · 2004 [cited by applicant]
US 20040261797A1 · White et al. · 2004 [cited by applicant]
US 20050028822A1 · Sleeper · 2005 [cited by examiner]
US 20050033247A1 · Thompson · 2005 [cited by examiner]
US 20050066976A1 · Wondka · 2005 [cited by examiner]
US 20060107958A1 · Sleeper · 2006 [cited by examiner]
US 20060180151A1 · Rinaldi · 2006 [cited by examiner]
US 20070283957A1 · Schobel · 2007 [cited by applicant]
US 20080060649A1 · Veliss et al. · 2008 [cited by applicant]
US 20080142019A1 · Lewis · 2008 [cited by applicant]
US 20080190436A1 · Jaffe et al. · 2008 [cited by applicant]
US 20090056711A1 · Richards et al. · 2009 [cited by applicant]
US 20090095303A1 · Sher et al. · 2009 [cited by applicant]
US 20090151729A1 · Judson et al. · 2009 [cited by applicant]
US 20090173349A1 · Hernandez et al. · 2009 [cited by applicant]
US 20090183739A1 · Wondka · 2009 [cited by applicant]
US 20100000534A1 · Kooij et al. · 2010 [cited by applicant]
US 20100018534A1 · Veliss et al. · 2010 [cited by applicant]
US 20100113955A1 · Colman et al. · 2010 [cited by applicant]
US 20100192957A1 · Hobson et al. · 2010 [cited by applicant]
US 20100224196A1 · Jablons · 2010 [cited by examiner]
US 20100252037A1 · Wondka et al. · 2010 [cited by applicant]
US 20110067704A1 · Kooij et al. · 2011 [cited by applicant]
US 20110126841A1 · Matula · 2011 [cited by applicant]
US 20110214676A1 · Allum et al. · 2011 [cited by applicant]
US 20110247619A1 · Formica et al. · 2011 [cited by applicant]
US 20120060845A1 · McKinnon · 2012 [cited by examiner]
US 20120111332A1 · Gusky et al. · 2012 [cited by applicant]
US 20120132209A1 · Rummery et al. · 2012 [cited by applicant]
US 20140000626A1 · O'Connor et al. · 2014 [cited by applicant]
US 20140130805A1 · Tiep et al. · 2014 [cited by applicant]
US 20140158127A1 · Boucher et al. · 2014 [cited by applicant]
US 20140332007A1 · Znamenskiy · 2014 [cited by applicant]
US 20160235937A1 · Ronayne et al. · 2016 [cited by applicant]
US 20170348500A1 · Johnson et al. · 2017 [cited by applicant]
US 20210379314A1 · Johnson et al. · 2021 [cited by applicant]
AU 2007278766 · 2018 [cited by applicant]
CA 2814601 · 2013 [cited by applicant]
CN 1905917A · 2007 [cited by applicant]
CN 101653632A · 2010 [cited by applicant]
CN 101977656A · 2011 [cited by applicant]
CN 101389369A · 2013 [cited by applicant]
EP 2130563 · 2009 [cited by applicant]
EP 1481702 · 2012 [cited by applicant]
EP 2022528 · 2016 [cited by applicant]
JP 3107788U · 2005 [cited by applicant]
JP 2007506480 · 2007 [cited by applicant]
JP 2009291615 · 2009 [cited by applicant]
JP 2009544371 · 2009 [cited by applicant]
JP 20115002229 · 2011 [cited by applicant]
JP 2011509762 · 2011 [cited by applicant]
JP 2011510707 · 2011 [cited by applicant]
JP 2012515562 · 2012 [cited by applicant]
JP 2012522608 · 2012 [cited by applicant]
JP 2013503720 · 2013 [cited by applicant]
JP 2013540037 · 2013 [cited by applicant]
WO WO2004073778 · 2004 [cited by applicant]
WO WO2005010608 · 2005 [cited by applicant]
WO WO2005018524 · 2005 [cited by applicant]
WO WO2006130903 · 2006 [cited by applicant]
WO WO2008011682 · 2008 [cited by applicant]
WO WO2008060587 · 2008 [cited by applicant]
WO WO2008070929 · 2008 [cited by applicant]
WO WO2009052560 · 2009 [cited by applicant]
WO WO2009109005 · 2009 [cited by applicant]
WO WO2010091157A2 · 2010 [cited by examiner]
WO WO2011029073 · 2011 [cited by applicant]
WO WO2011062510 · 2011 [cited by applicant]
WO WO2012053910 · 2012 [cited by applicant]
WO WO2012053910A1 · 2012 [cited by examiner]
WO WO2013014581 · 2013 [cited by applicant]
WO WO2014142681 · 2014 [cited by applicant]
WO WO2015057083 · 2015 [cited by applicant]
WO WO2016157103 · 2016 [cited by applicant]
International Search Report, PCT/NZ2015/050156, dated Nov. 10, 2015, in 5 pages. [cited by applicant]
International Search Report and Written Opinion; PCT/NZ2014/000217; date Jan. 12, 2015; 21 pages. [cited by applicant]
Extended European Search Report, PCT/NZ2015/050156; dated Feb. 20, 2018; 8 pages. [cited by applicant]